Caplacizumab in acquired thrombotic thrombocytopenic Purpura (aTTP): Long-term Safety and Efficacy in the Post-HERCULES Study
Por:
Knobl, P, Scully, M, de la Rubia, J, Pavenski, K, Metjian, A, Peyvandi, F, Cataland, S, Coppo, P, Hovinga, K, Edou, M, Sousa, D, Callewaert, F, Gunawardena, S and Lin, J
Publicada:
1 sep 2022
Resumen:
Filiaciones:
Knobl, P:
Med Univ Vienna, Div Hematol & Hemostasis, Dept Med 1, Vienna, Austria
Scully, M:
Univ Coll London Hosp, Dept Haematol, London, England
:
Catholic Univ Valencia, Valencia, Spain
Hosp Doctor Peset, Dept Hematol, Internal Med, Sch Med & Dent, Valencia, Spain
Pavenski, K:
St Michaels Hosp, Toronto, ON, Canada
Univ Toronto, Dept Med, Toronto, ON, Canada
Univ Toronto, Dept Lab Med, Toronto, ON, Canada
Metjian, A:
Univ Colorado, Div Hematol, Dept Med, Anschutz Med Ctr, Denver, CO USA
Peyvandi, F:
Fdn IRCCS Ca Granda Osped Maggiore Policlin, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy
Fdn IRCCS Ca Granda Osped Maggiore Policlin, Fdn Luigi Villa, Milan, Italy
Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy
Cataland, S:
Ohio State Univ, Dept Internal Med, Columbus, OH USA
Coppo, P:
St Antoine Univ Hosp, Dept Hematol, Reference Ctr Thrombot Microangiopathies CNR MAT, Paris, France
Hovinga, K:
Univ Bern, Bern Univ Hosp, Dept Hematol, Bern, Switzerland
Univ Bern, Bern Univ Hosp, Cent Hematol Lab, Bern, Switzerland
Edou, M:
Sanofi, Zwijnaarde, Belgium
Sousa, D:
Sanofi, Lisbon, Portugal
Callewaert, F:
Sanofi, Diegem, Belgium
Gunawardena, S:
Sanofi, Cambridge, MA USA
Lin, J:
Sanofi, Cambridge, MA USA
|